H. Rauer et al., Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin, J BIOL CHEM, 274(31), 1999, pp. 21885-21892
The structurally defined sea anemone peptide toxins ShK and BgK potently bl
ock the intermediate conductance, Ca2+-activated potassium channel IKCa1, a
well recognized therapeutic target present in erythrocytes, human T-lympho
cytes, and the colon. The well characterized voltage-gated Kv1.3 channel in
human T-lymphocytes is also blocked by both peptides, although ShK has a s
imilar to 1,000-fold greater affinity for Kv1.3 than IKCa1. To gain insight
into the architecture of the toxin receptor in IKCa1, we used alanine-scan
ning in combination with mutant cycle analyses to map the ShK-IKCa1 interfa
ce, and compared it with the ShK-Kv1.3 interaction surface. ShK uses the sa
me five core residues, all clustered around the critical Lys(22), to intera
ct with IKCa1 and Kv1.3, although it relies on a larger number of contacts
to stabilize its weaker interactions with IKCa1 than with Kv1.3. The toxin
binds to IKCa1 in a region corresponding to the external vestibule of Kv1.3
, and the turret and outer pore of the structurally defined bacterial potas
sium channel, KcsA. Based on the NMR structure of ShK, we deduce the toxin
receptor in IKCa1 to have x-y dimensions of similar to 22 Angstrom, a diame
ter of similar to 31 Angstrom, and a depth of similar to 8 Angstrom; we est
imate that the ion selectivity lies similar to 13 Angstrom below the outer
lip of the toxin receptor, These dimensions are in good agreement with thos
e of the KcsA channel determined from its crystal structure, and the inferr
ed structure of Kv1.3 based on mapping with scorpion toxins. Thus, these di
stantly related channels exhibit architectural similarities in the outer po
re region. This information could facilitate development of specific and po
tent modulators of the therapeutically important IKCa1 channel.